A nanosystem of copper(II)-disulfiram for cancer treatment with high efficacy and few side effects

Liping ZHAO , Xiaoxia WANG , Mingxia JIANG , Xinghan WU , Mogen ZHANG , Xiuwen GUAN , Jinlong MA , Weifen ZHANG

Front. Mater. Sci. ›› 2021, Vol. 15 ›› Issue (4) : 553 -566.

PDF (6904KB)
Front. Mater. Sci. ›› 2021, Vol. 15 ›› Issue (4) : 553 -566. DOI: 10.1007/s11706-021-0576-2
RESEARCH ARTICLE
RESEARCH ARTICLE

A nanosystem of copper(II)-disulfiram for cancer treatment with high efficacy and few side effects

Author information +
History +
PDF (6904KB)

Abstract

Developing chemotherapy drugs with high efficacy and few side effects has been a bottleneck problem that requires an efficient solution. The active cancer treatment ingredient disulfiram (DSF), inspired by the copper(II) diethyldithiocarbamate complex (CuET), can be used in a one-pot synthesis method to construct a CuET delivery nanosystem (CuET-ZIFCu@HA). Due to the high biocompatibility, targeting of CD44 overexpressed cancer cells, and acid response of zeolitic imidazolate framework (ZIF) materials of hyaluronic acid (HA), we realized that CuET-ZIFCu@HA could become an effective and highly selective cancer treatment. Both in vivo and in vitro experiments have demonstrated that CuET-ZIFCu@HA has robust anti-tumor properties without evident side effects. This research provided a promising strategy for DSF nanosystems that involves simple preparation and high efficacy, both of which are key to reusing DSF in cancer treatment.

Graphical abstract

Keywords

disulfiram / copper(II) diethyldithiocarbamate complex / zeolitic imidazolate framework / targeted therapy

Cite this article

Download citation ▾
Liping ZHAO, Xiaoxia WANG, Mingxia JIANG, Xinghan WU, Mogen ZHANG, Xiuwen GUAN, Jinlong MA, Weifen ZHANG. A nanosystem of copper(II)-disulfiram for cancer treatment with high efficacy and few side effects. Front. Mater. Sci., 2021, 15(4): 553-566 DOI:10.1007/s11706-021-0576-2

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Qiu L, Chen T, Öçsoy I, . A cell-targeted, size-photocontrollable, nuclear-uptake nanodrug delivery system for drug-resistant cancer therapy. Nano Letters, 2015, 15(1): 457–463

[2]

Ma J, Hu Z, Wang W, . pH-sensitive reversible programmed targeting strategy by the self-assembly/disassembly of gold nanoparticles. ACS Applied Materials & Interfaces, 2017, 9(20): 16767–16777

[3]

Zhang L, Wan S S, Li C X, . An adenosine triphosphate-responsive autocatalytic fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion. Nano Letters, 2018, 18(12): 7609–7618

[4]

Wang J, Wu X, Shen P, . Applications of inorganic nanomaterials in photothermal therapy based on combinational cancer treatment. International Journal of Nanomedicine, 2020, 15: 1903–1914

[5]

Ding Y, Xu H, Xu C, . A nanomedicine fabricated from gold nanoparticles-decorated metal-organic framework for cascade chemo/chemodynamic cancer therapy. Advanced Science, 2020, 7(17): 2001060

[6]

Gu Z, Zhu S, Yan L, . Graphene-based smart platforms for combined cancer therapy. Advanced Materials, 2019, 31(9): 1800662

[7]

Bao X, Yuan Y, Chen J, . In vivo theranostics with near-infrared-emitting carbon dots-highly efficient photothermal therapy based on passive targeting after intravenous administration. Light: Science & Applications, 2018, 7(1): 91

[8]

Majera D, Skrott Z, Bouchal J, . Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram. Prostate, 2019, 79(4): 352–362

[9]

Skrott Z, Mistrik M, Andersen K K, . Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature, 2017, 552(7684): 194–199

[10]

Zhou L, Yang L, Yang C, . Membrane loaded copper oleate PEGylated liposome combined with disulfiram for improving synergistic antitumor effect in vivo. Pharmaceutical Research, 2018, 35(7): 147

[11]

Skrott Z, Majera D, Gursky J, . Disulfiram’s anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase. Oncogene, 2019, 38(40): 6711–6722

[12]

Wang K, Michelakos T, Wang B, . Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation. Cancer Letters, 2021, 505: 37–48

[13]

Zhang L, Tian B, Li Y, . A copper-mediated disulfiram-loaded pH-triggered PEG-shedding TAT peptide-modified lipid nanocapsules for use in tumor therapy. ACS Applied Materials & Interfaces, 2015, 7(45): 25147–25161

[14]

Peng X, Pan Q, Zhang B, . Highly stable, coordinated polymeric nanoparticles loading copper(II) diethyldithiocarbamate for combinational chemo/chemodynamic therapy of cancer. Biomacromolecules, 2019, 20(6): 2372–2383

[15]

Yang Q, Yao Y, Li K, . An updated review of disulfiram: Molecular targets and strategies for cancer treatment. Current Pharmaceutical Design, 2019, 25(30): 3248–3256

[16]

Yang Y, Wang F, Yang Q, . Hollow metal-organic framework nanospheres via emulsion-based interfacial synthesis and their application in size-selective catalysis. ACS Applied Materials & Interfaces, 2014, 6(20): 18163–18171

[17]

Wang D, Zhou J, Chen R, . Controllable synthesis of dual-MOFs nanostructures for pH-responsive artemisinin delivery, magnetic resonance and optical dual-model imaging-guided chemo/photothermal combinational cancer therapy. Biomaterials, 2016, 100: 27–40

[18]

Liu D, Wan J, Pang G, . Hollow metal-organic-framework micro/nanostructures and their derivatives: Emerging multifunctional materials. Advanced Materials, 2019, 31(38): 1803291

[19]

Zhang S, Pei X, Gao H, . Metal-organic framework-based nanomaterials for biomedical applications. Chinese Chemical Letters, 2020, 31(5): 1060–1070

[20]

Wu Q, Li M, Tan L, . A tumor treatment strategy based on biodegradable BSA@ZIF-8 for simultaneously ablating tumors and inhibiting infection. Nanoscale Horizons, 2018, 3(6): 606–615

[21]

Shu F, Lv D, Song X L, . Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging. RSC Advances, 2018, 8(12): 6581–6589

[22]

Dissegna S, Epp K, Heinz W R, . Defective metal-organic frameworks. Advanced Materials, 2018, 30(37): 1704501

[23]

Zheng H, Zhang Y, Liu L, . One-pot synthesis of metal-organic frameworks with encapsulated target molecules and their applications for controlled drug delivery. Journal of the American Chemical Society, 2016, 138(3): 962–968

[24]

Zhang W, Lu J, Gao X, . Enhanced photodynamic therapy by reduced levels of intracellular glutathione obtained by employing a nano-MOF with CuII as the active center. Angewandte Chemie International Edition, 2018, 57(18): 4891–4896

[25]

Burtch N C, Heinen J, Bennett T D, . Mechanical properties in metal-organic frameworks: Emerging opportunities and challenges for device functionality and technological applications. Advanced Materials, 2018, 30(37): 1704124

[26]

Luo Z, Dai Y, Gao H. Development and application of hyaluronic acid in tumor targeting drug delivery. Acta Pharmaceutica Sinica B, 2019, 9(6): 1099–1112

[27]

Liu R, Xiao W, Hu C, . Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis. Journal of Controlled Release, 2018, 278: 127–139

[28]

Wang Z, Chen Z, Liu Z, . A multi-stimuli responsive gold nanocage-hyaluronic platform for targeted photothermal and chemotherapy. Biomaterials, 2014, 35(36): 9678–9688

[29]

Qin Y T, Peng H, He X W, . pH-responsive polymer-stabilized ZIF-8 nanocomposites for fluorescence and magnetic resonance dual-modal imaging-guided chemo-/photodynamic combinational cancer therapy. ACS Applied Materials & Interfaces, 2019, 11(37): 34268–34281

[30]

Su L, Wu Q, Tan L, . High biocompatible ZIF-8 coated by ZrO2 for chemo-microwave thermal tumor synergistic therapy. ACS Applied Materials & Interfaces, 2019, 11(11): 10520–10531

[31]

Tang Z, Liu Y, He M, . Chemodynamic therapy: Tumour microenvironment-mediated fenton and fenton-like reactions. Angewandte Chemie International Edition, 2019, 58(4): 946–956

[32]

Wu W, Yu L, Jiang Q, . Enhanced tumor-specific disulfiram chemotherapy by in situ Cu2+ chelation-initiated nontoxicity-to-toxicity transition. Journal of the American Chemical Society, 2019, 141(29): 11531–11539

[33]

Peng Y, Liu P, Meng Y, . Nanoscale copper(II)–diethyldithiocarbamate coordination polymer as a drug self-delivery system for highly robust and specific cancer therapy. Molecular Pharmaceutics, 2020, 17(8): 2864–2873

[34]

Hua Y, Lv X, Cai Y, . Highly selective and reproducible electroanalysis for histidine in blood with turn-on responses at a potential approaching zero using tetrahedral copper metal organic frameworks. Chemical Communications, 2019, 55(9): 1271–1274

[35]

Liu Y, Bhattarai P, Dai Z, . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chemical Society Reviews, 2019, 48(7): 2053–2108

[36]

Zhang M, Guo X, Wang M, . Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery-associated challenges. Journal of Controlled Release, 2020, 323: 203–224

[37]

Wang Y, Wu W, Liu J, . Cancer-cell-activated photodynamic therapy assisted by Cu(II)-based metal-organic framework. ACS Nano, 2019, 13(6): 6879–6890

RIGHTS & PERMISSIONS

Higher Education Press

AI Summary AI Mindmap
PDF (6904KB)

3063

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/